SCHEMBL24715901

SCHEMBL24715901

Oc1cccc2c(C3CCCCC3)ccnc12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 11/20 0.49
LMNA P02545 4/20 0.49
MAPT P10636 3/20 0.49
TP53 P04637 2/20 0.49
ALOX12 P18054 2/20 0.49
TSHR P16473 2/20 0.49
L3MBTL1 Q9Y468 7/20 0.46
RAB9A P51151 2/20 0.46
KDM4A O75164 1/20 0.46
EGLN1 Q9GZT9 1/20 0.46
HIF1AN Q9NWT6 1/20 0.46
COMT P21964 2/20 0.45
BRD4 O60885 2/20 0.40
GAA P10253 2/20 0.40
ALDH1A1 P00352 1/20 0.40
NFKB1 P19838 1/20 0.40
NFKB2 Q00653 1/20 0.40
RELA Q04206 1/20 0.40
METAP2 P50579 2/20 0.40
METAP1 P53582 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17931872 0.91 COMT (0.55) KDM4ELMNAMAPTTP53ALOX12
SCHEMBL29856077 0.82 KDM4E (0.54) KDM4ELMNAMAPTALOX12TSHR
SCHEMBL24715878 0.78 HTR1A (0.50) ADRA1ASLC6A2
SCHEMBL13004751 0.76 ESR1 (0.47) MAPTTSHRALDH1A1HDAC8HSP90AA1
SCHEMBL25256999 0.76 HTR1A (0.51) ADRA1ASLC6A2
Hydrochloric Acid SCHEMBL9069894 0.74 IDO1 (0.55) KDM4ELMNAMAPTTP53ALOX12
SCHEMBL20935332 0.73 CAMKK1 (0.51) KDM4EMAPTTP53TSHRL3MBTL1
SCHEMBL11002147 0.73 IDO1 (0.53) MAPTTSHRALDH1A1HDAC8HSP90AA1
SCHEMBL24715876 0.73 KDM4E (0.41) KDM4ELMNAMAPTL3MBTL1COMT
SCHEMBL24715890 0.73 FEN1 (0.36) KDM4EALOX12L3MBTL1RAB9AMMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4623914-A1 USE OF 8-HYDROXYQUINOLINE DERIVATIVE Jiangsu Yahong Meditech Co., Ltd. (CN) 2025-10-01 EP disclosed
CN-120035438-A Use of 8-hydroxyquinoline derivatives 江苏亚虹医药科技股份有限公司 2025-05-23 CN disclosed
US-20240246916-A1 7-NITRO-8-HYDROXYQUINOLINE DERIVATIVES, PREPARATION METHOD THEREFORE AND MEDICAL USE THEREOF JIANGSU YAHONG MEDITECH CO., LTD. (CN) 2024-07-25 US disclosed
CN-118059101-A Use of 8-hydroxyquinoline derivatives 江苏亚虹医药科技股份有限公司 2024-05-24 CN disclosed
EP-4349815-A1 7-NITRO-8-HYDROXYQUINOLINE DERIVATIVE, PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF Jiangsu Yahong Meditech Co., Ltd. (CN) 2024-04-10 EP disclosed
CN-117043141-A 7-nitro-8-hydroxyquinoline derivative, preparation method and medical application thereof 江苏亚虹医药科技股份有限公司 2023-11-10 CN disclosed
WO-2022253152-A1 7-NITRO-8-HYDROXYQUINOLINE DERIVATIVE, PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF 江苏亚虹医药科技股份有限公司 2022-12-08 WO disclosed
WO-2022253152-A1 7-NITRO-8-HYDROXYQUINOLINE DERIVATIVE, PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF 江苏亚虹医药科技股份有限公司 2022-12-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240246916-A1 7-NITRO-8-HYDROXYQUINOLINE DERIVATIVES, PREPARATION METHOD THEREFORE AND MEDICAL USE THEREOF CYP3A7, UGT1A7, UGT2B7 KDM4E 2921/4885LMNA 2723/4885MAPT 4416/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.